ArticleClinical and translational medicine2026

Baseline multi-omics signatures could predict therapeutic response to neoadjuvant anti-PD-1 immunochemotherapy in non-small-cell lung cancer.

Ailing Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.